PORT WASHINGTON, N.Y.--(BUSINESS WIRE)--ForteBio, a division of Pall Life Sciences and a leading supplier of instrumentation for accelerated drug discovery and development, today announced the launch ...
ForteBio, Inc. has announced the commercial introduction of the company's first product, the Octet™ System for label-free, real-time detection and analysis of molecular interactions. Octet is designed ...
ForteBio®, Inc. has announced that it has launched two new assay modules - for high-sensitivity protein quantitation and fragment screening, respectively - for use on the company's Octet® ...
ForteBio Launches New Dip and Read™ Anti-FLAG Biosensor to Facilitate Protein Research and Drug Deve
The Dip and Read(TM) Anti-FLAG Biosensor for use on ForteBio's Octet(R) and BLItz(TM) instrumentation systems enables researchers to quickly and easily detect FLAG-tagged recombinant proteins for ...
Octet and Multi-Analyte Software Tool Help Facilitate Development of Quantitation Assay Scientific projects are driven by the delivery of quality analytical data at the right time. The lack of robust ...
MENLO PARK, Calif., March 3 /PRNewswire/ -- ForteBio(R), Inc., a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, today ...
MENLO PARK, Calif. September 23, 2008 - ForteBio®, Inc., a leading supplier of label-free technology that accelerates the development oflife science and pharmaceutic products, today announced the ...
ForteBio LLC is a wholly-owned subsidiary of Pall Corp. and a division of Pall Life Sciences. ForteBio develops analytical systems that enable real-time analysis of biomolecular interactions (protein ...
PORT WASHINGTON, N.Y.--(BUSINESS WIRE)--ForteBio, a division of Pall Life Sciences and a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback